Liposomal Nano-Based Drug Delivery Systems for Breast Cancer Therapy: Recent Advances and Progresses
M Yazdan, SM Naghib… - Anti-Cancer Agents in …, 2024 - ingentaconnect.com
Breast cancer is a highly prevalent disease on a global scale, with a 30% incidence rate
among women and a 14% mortality rate. Developing countries bear a disproportionate …
among women and a 14% mortality rate. Developing countries bear a disproportionate …
MUC1 aptamer-tethered H40-TEPA-PEG nanoconjugates for targeted siRNA-delivery and gene silencing in breast cancer cells
With a prevalence of 12.5% of all new cancer cases annually, breast cancer stands as the
most common form of cancer worldwide. The current therapies utilized for breast cancer are …
most common form of cancer worldwide. The current therapies utilized for breast cancer are …
Liposome‐Based Delivery of a Bis‐benzimidazole Derivative to Duplex DNA: A Spectroscopic Study
D Shit, P Mandal, P Das, S Pramanik - ChemistrySelect, 2024 - Wiley Online Library
Due to the immense pharmacological significance, the interaction of small molecules with
liposome and the exact knowledge of their binding location and distribution within the lipid …
liposome and the exact knowledge of their binding location and distribution within the lipid …
Lipid nanoparticles in colorectal cancer
S Bhattacharya, BG Prajapati - Colorectal Cancer, 2024 - Elsevier
The global burden of colorectal cancer (CRC) is enormous, and postoperative death rates
for individuals with late-stage CRC are often significant. Adjuvant chemotherapeutics (ACs) …
for individuals with late-stage CRC are often significant. Adjuvant chemotherapeutics (ACs) …